Ahmadpanah Mohammad, Haghighi Mohammad, Jahangard Leila, Borzoei Shiva, Heshmati Safora, Bajoghli Hafez, Holsboer-Trachsler Edith, Brand Serge
a Research Center for Behavioral Disorders and Substance Abuse, Hamadan University of Medial Sciences , Hamadan , Iran.
Int J Psychiatry Clin Pract. 2015;19(3):168-73. doi: 10.3109/13651501.2015.1049277. Epub 2015 Jun 9.
The aim of the present study was to provide further evidence of (1) metabolic syndrome and blood lipid profile differences between suicide attempting and non-attempting patients with bipolar disorder (BPD) I and to assess these differences (2) as a function of acute depressive or manic phase.
Fifty inpatients (mean age: 36.14 years 48% males) with BPD I took part in the study. After recruitment, patients were clustered in four groups: 13 suicide attempters (SAs) assessed during a manic phase, 12 SAs assessed during a depressive phase, 15 non-SAs assessed during a manic phase, and 10 non-SAs assessed during a depressive phase. Body mass index (BMI), metabolic syndrome, blood pressure, blood lipids (cholesterol, high- and low-density lipids, and triglyceride), and fasting blood sugar were assessed.
Neither metabolic syndrome, blood lipid values, fasting blood sugar, nor BMI or blood pressure differed between the SAs and non-SAs, or between patients in an acute manic phase and those in a depressed phase. The overall prevalence of metabolic syndrome was 26.0%.
Among patients with BPD I neither the occurrence of metabolic syndrome nor lipid values or fasting blood sugar are reliable biomarkers of suicidal behavior during either acute depressive or manic phase.
本研究旨在进一步证明(1)双相情感障碍I型(BPD)自杀未遂与未自杀患者之间的代谢综合征及血脂谱差异,并(2)评估这些差异与急性抑郁或躁狂相的关系。
50例双相情感障碍I型住院患者(平均年龄:36.14岁;48%为男性)参与了本研究。招募后,患者被分为四组:13例在躁狂相评估的自杀未遂者(SAs),12例在抑郁相评估的SAs,15例在躁狂相评估的非SAs,以及10例在抑郁相评估的非SAs。评估了体重指数(BMI)、代谢综合征、血压、血脂(胆固醇、高密度和低密度脂蛋白以及甘油三酯)和空腹血糖。
SAs与非SAs之间,或急性躁狂相患者与抑郁相患者之间,代谢综合征、血脂值、空腹血糖、BMI或血压均无差异。代谢综合征的总体患病率为26.0%。
在双相情感障碍I型患者中,无论是急性抑郁相还是躁狂相,代谢综合征的发生、血脂值或空腹血糖都不是自杀行为的可靠生物标志物。